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Historical Lassa
Fever Reports and
30-year Clinical
Update
Abe M. Macher* and Martin S. Wolfe†‡§
Five cases of Lassa fever have been imported from
West Africa to the United States since 1969. We report
symptoms of the patient with the second imported case and
the symptoms and long-term follow-up on the patient with
the third case. Vertigo in this patient has persisted for 30
years.

assa fever is a viral hemorrhagic fever caused by a
rodentborne arenavirus that is endemic in West Africa.
In 2004, the Centers for Disease Control and Prevention
(CDC) reported a fatal case of Lassa fever in New Jersey
(1). CDC noted that ≈20 imported cases of Lassa fever had
been seen outside West Africa. Five patients with imported disease have been hospitalized in the United States
(Table). We report the signs and symptoms of the second
patient in this group of 5 patients and the signs and symptoms and long-term follow-up of the third patient, both aid
workers who became ill in 1975 while serving in Sierra
Leone. Their clinical courses were complicated by severe
neurologic dysfunction, including unilateral sensorineural
deafness and vertigo.

L

Case 1
In February 1975, a 26-year-old American aid worker
in Sierra Leone was hospitalized with severe abdominal
pain. No cause was determined, and she was discharged. In
March 1975, watery diarrhea, fever, chills, headache,
myalgias, arthralgias, and conjunctival injection developed. She was hospitalized, and physical examination
showed posterior cervical, axillary, and inguinal lymphadenopathy. She was empirically treated for malaria and
amebiasis.
Nevertheless, fever persisted, she lost 2.7 kg, and pleuritic chest pain developed. In April 1975, she was air evacuated and admitted to a hospital in Washington, DC.
Although she was afebrile, generalized lymphadenopathy
was still present, and a chest radiograph showed left-sided
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pleural effusion. Thoracentesis fluid was remarkable for
eosinophilia, and examinations of blood showed 3%–35%
peripheral eosinophilia. Knott’s preparation of blood
showed 3 sheathed microfilariae with nuclei extending
into the tail, presumed to be Loa loa. A cervical lymph
node biopsy showed follicular hyperplasia.
She was convalescing in the hospital when suddenly,
while speaking on the telephone, she lost hearing unilaterally. An audiogram demonstrated unilateral sensorineural
deafness. A serum specimen collected in May 1975 was
sent to CDC, where an indirect fluorescent antibody (IFA)
titer of 256 was demonstrated against Lassa fever virus (P.
Rollin, pers. comm.). She was discharged with residual
unilateral deafness.
Case 2
In December 1975, abdominal cramps, nausea, vomiting, diarrhea, fatigue, headaches, retroorbital pain, aching
shoulders, and severe low back pain developed in a 43year-old American aid worker in Sierra Leone.1 Her aching
progressed to total body pain, which she described as
“severe pain in her bones, as if they were breaking” (from
patient’s medical chart). Her symptoms persisted, and in
February 1976, nocturnal fevers and sweats developed.
She experienced dizziness and syncope and was hospitalized. She was hypotensive with blood pressure as low as
70/40 mm Hg (compared to 120/80 mm Hg in June 1975)
and had insomnia. She was empirically treated for malaria
and discharged. Her symptoms reappeared, accompanied
by persistent vomiting, shooting pain in the right ear, neck
pain, paresthesias, and alopecia. She lost 4 kg. In March
1976, she was air evacuated and admitted to a hospital in
Washington, DC.
During her hospitalization in Washington, she was
afebrile. However, fatigue, headache, neck pain, nausea,
low back pain, and insomnia persisted. She had costochondral and diffuse abdominal tenderness and ecchymoses at
intramuscular injection sites (antiemetics). She was unable
to read for more than a few minutes, as her eyes would tire
and begin to hurt. She experienced dysmorphopsias, difficulty with hearing, severe depression, and numerous
episodes of lightheadedness, unsteadiness, dizziness, and
vertigo. Vertigo occurred in both supine and standing positions up to 5 times per day. Although she was hypotensive,
she was not orthostatic. Neurologic examination found leftsided facial weakness, right-sided Babinski reflex, and the
Weber test lateralized to the left. Audiometry and positional and caloric nystagmography results were unremarkable.
A serum specimen obtained on March 1 showed an IFA
titer of 64 against Lassa virus. Lassa virus was recovered
1Portions

of this patient’s clinical signs and symptoms were originally published in Zweighaft et al. (2).
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from a March 3 urine specimen. On March 10, a serum
specimen demonstrated a complement fixation antibody
titer of 16, a 4-fold rise compared to a titer <4 in a
February 25 specimen drawn in Sierra Leone.
Although her vertigo persisted, she became normotensive (120/80 mm Hg) on March 28, 1976, and was discharged. However, during the next 30 years, she continued
to experience fatigue, generalized weakness, headache,
insomnia, depression, dysmorphopsias, paresthesias, lightheadedness, dizziness and syncope, and labile hypotension. She describes “fatigue so severe that I have no energy
for days,” “staggering when getting up,” “inability to produce words at times,” and “spells of loss of consciousness”
(up to 15 minutes in duration, as noted by her husband). In
1992, a magnetic resonance imaging scan of the brain
demonstrated periventricular hyperintense signals. As of
February 2006, her symptoms persist.
Conclusions
Auditory or vestibular dysfunction may develop in
patients with Lassa fever, and tinnitus, autophony, hearing
loss, dizziness, vertigo, nystagmus, and ataxia have been
reported (3,4). In their review of a 1989 nosocomial Lassa
fever outbreak in a Nigerian hospital, Fisher-Hoch et al.
(3) noted a high fever in the index patient, who was taken
to surgery on February 25. The patient bled profusely and
died later that night. The surgical nurse and a student nurse
who washed blood-soaked cloths both became ill with
febrile illnesses on March 7. Both became serologically
positive for Lassa fever virus. The surgical nurse was
traced to her village, where she was found to be almost
totally deaf and severely ataxic.
Onset of deafness among patients with Lassa fever is a
feature of the convalescent phase rather than the acute
phase of the illness (4). Deafness was first reported as a
complication of Lassa fever by White (5) and Henderson
(6) in 1972. White noted that during a 1970 nosocomial
836

hospital outbreak in Jos, Nigeria, deafness occurred in 4 of
23 hospitalized patients; a fifth patient reported intermittent tinnitus, and 3 patients experienced dizziness.
Among the now 24 reported patients with imported
Lassa fever worldwide (1969–2004, Appendix Table), our
26-year-old aid worker is the only patient whose clinical
course has been complicated by sensorineural deafness.
Our second patient’s clinical course has been remarkable
for an array of acute and chronic neurologic and neuropsychiatric complications, including left-sided facial weakness, right-sided Babinski reflex, headache, paresthesias,
vertigo, syncope, dysmorphopsias, fatigue, insomnia, and
depression. Rose (7,8) reported a 1955–1956 outbreak of
encephalomyelitis in Sierra Leone, which may represent
the earliest recorded clinical description of Lassa fever;
remarkably, vertigo developed in 30 of his 45 patients.
Solbrig and McCormick (9) reported that neuropsychiatric
sequelae of Lassa fever have included sleep disorders (e.g.,
insomnia), asthenia, multiple somatic complaints, psychosis, hallucinations, personality disorders, severe adjustment reactions, dementia, mania, and depression. Finally,
our patient’s ongoing labile hypotension may represent
Lassa fever–induced damage to the brain stem with resultant autonomic dysfunction. Since our patient’s array of
persistent neurologic and neuropsychiatric symptoms have
not changed, improved, or progressed since her episode of
Lassa fever, we believe that they all may represent sequelae of Lassa fever–induced damage to the brain.
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